Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 
This article has been cited by
1Elevated RTP801 promotes cell proliferation in non-small cell lung cancer
Jianyou Su,Hua Huang,Shaoqing Ju,Jiahai Shi
IUBMB Life.2018;70(4)310
[DOI]
2Systemic Therapy for Elderly Patients With Advanced Non–Small-Cell Lung Cancers
Paul A. Bunn,Anastasios Dimou
Journal of Clinical Oncology.2018;36(25)2571
[DOI]
3Angiogenesis inhibitors for the treatment of small cell lung cancer (SCLC)
Qing Li,Tao Wu,Li Jing,Miao-Jing Li,Tao Tian,Zhi-Ping Ruan,Xuan Liang,Ke-Jun Nan,Zhi-Yan Liu,Yu Yao,Hui Guo
Medicine.2017;96(13)e6412
[DOI]
4Systemic therapy for elderly patients with non–small cell lung cancer: Where do we stand in 2019?
Charu Aggarwal,Corey J. Langer
Cancer.2020;126(5)931
[DOI]
5Treatment of elderly patients or patients who are performance status 2 (PS2) with advanced Non-Small Cell Lung Cancer without epidermal growth factor receptor ( EGFR ) mutations and anaplastic lymphoma kinase ( ALK ) translocations – Still a daily challenge
Chunxia Su,Fei Zhou,Jiqiao Shen,Jing Zhao,Mary O'Brien
European Journal of Cancer.2017;83(5)266
[DOI]
6Treatment of advanced non-small cell lung cancer in the elderly
Paola C. Sacco,Paolo Maione,Giovanni Palazzolo,Cesare Gridelli
Expert Review of Respiratory Medicine.2018;12(9)783
[DOI]

Subscribe this journal
Submit articles
Most popular articles
Joiu us as a reviewer
Email alerts
Recommend this journal